Overview
- 33 inspections across 33 sites are on record.
- 54 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-09-22.
At a glance
Inspections
33
Sites
33
Observations
54
Career since
Sep 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| MicroBiopharm Japan Co., Ltd. | 22 Sep 2017 | Human Drugs | On file |
| Hisamitsu Pharmaceutical Co., Inc. | 15 Sep 2017 | Human Drugs | View 483 → |
| Kyowa Hakko Bio Co., Ltd. | 8 Sep 2017 | Human Drugs | On file |
| Macco Organiques Inc | 15 Dec 2016 | Human Drugs | |
| Tubilux Pharma Spa | 9 Dec 2016 | Human Drugs | View 483 → |
Sites inspected
MicroBiopharm Japan Co., Ltd.Yatsushiro, Japan1 insp.
Hisamitsu Pharmaceutical Co., Inc.Tosu, Japan1 insp.
Kyowa Hakko Bio Co., Ltd.Hofu, Japan1 insp.
Macco Organiques IncSalaberry-De-Valleyfield, Canada1 insp.
Tubilux Pharma SpaPomezia, Italy1 insp.
Co-investigators
Investigators who share inspections with this person.
Ivis L Negron Torres4 shared
Jose R Lopez3 shared
Teresa I Navas2 shared
Victor S Pacheco2 shared
Nancy Rosado2 shared
Christopher D Leach1 shared
Merideth K Rose1 shared
Concepcion Cruz1 shared
Jorge L Lajara1 shared
Rafael Gonzalez1 shared
Full investigator report
Get the verbatim findings behind Milva E Melendez's 54 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site